Dr David O. Oluwole
Academic and research departments
School of Chemistry and Chemical Engineering, Faculty of Engineering and Physical Sciences.About
Biography
Experienced Scientist with a proven research record in Medicinal Chemistry, Colloid Chemistry, Spectroscopy, Drug Design and Development, Formulation, Chromatography, Mammalian Cell-Based Assay, and Pharmaceutical Analysis. Astute administrative professional with a Doctor of Philosophy in Chemistry (2016) from Rhodes University, South Africa, and an h–index of 17. Proficient in scientific/grant writing, public speaking, research project ideation and implementation as well as supervision of students. Currently, I serve on the editorial board of Frontiers in Chemistry as an Associate Editor.
ResearchResearch interests
Dr Oluwole's research focuses on the development of compounds/formulations that can be explored for both diagnostic and therapeutic purposes, improving health and wellbeing with high specificity. Specifically, these involves the synthesis of novel functional compounds/formulations for the treatment of tumourigenic cells and chronic wounds.
Research interests
Dr Oluwole's research focuses on the development of compounds/formulations that can be explored for both diagnostic and therapeutic purposes, improving health and wellbeing with high specificity. Specifically, these involves the synthesis of novel functional compounds/formulations for the treatment of tumourigenic cells and chronic wounds.
Publications
Impairment of the skin’s structural integrity initially results in acute wounds which can become chronic if timely wound closure is not achieved. Chronic wounds (CWs) affect more than 1% of the global population with increasing cases of this condition due to the ageing population. Current wound management relies on debridement, hyperbaric oxygen, antibiotics, and wound dressings, which lack early intervention and specificity. Herein, antibiotics-free retinol-based micellar formulations (RMF) were made and their wound healing efficacy were investigated in vitro. Five different formulations with retinol contents of 0.3% and 1% against a placebo were topically applied to an organotypic full-thickness skin wound model (FT-SWM, MatTek®) with a 3 mm punch wound, and maintained in an incubator for 6 days. The histological analysis of the FT-SWM was conducted at depths of 60 µm and 80 µm. It was found that all the micellar retinol formulations accelerated wound bed contraction, with 0.3% RMF demonstrating the highest efficacy. At the depths of 60 µm and 80 µm, the 0.3% RMF exhibited inner wound diameter contraction of 58% and 77%, respectively, in comparison to the placebo showing 15% and 8%. The RMF significantly accelerated wound healing and can thus be a potential early intervention for speedy wound recovery. It should be pointed out that these results were obtained based on a small sample size and a large sample size will be explored to further validate the results.
Novel chloroindium(III) complexes of tetra(4-methylthiophenyl)porphyrin (2a) and tetra-2-thienylporphyrin (2b) dyes have been synthesized and characterized. The main goal of the project was to identify fully symmetric porphyrin dyes with Q-band regions that lie partially in the therapeutic window that are suitable for use in photodynamic therapy (PDT). 2a and 2b were found to have fluorescence quantum yield values
A 2,6-diiodo-3,5-dithienylvinyleneBODIPY dye was prepared and encapsulated with folate-chitosan capped Pluronic (R) F-127 to provide drug delivery systems for photodynamic therapy (PDT). Moderately enhanced singlet oxygen quantum yields were observed for the dye encapsulation complexes in water. The in vitro dark cytotoxicity and photodynamic activity were investigated on the human breast adenocarcinoma (MCF-7) cell line. Minimal dark cytotoxicity was observed for the BODIPY dyes in 5% DMSO and when encapsulated in folate-functionalized chitosan-coated Pluronic (R) F-127 micelles, since the cell viability values are consistently greater than 80% over the 0-40 mu g.mL(-1) concentration range. Upon irradiation of the samples, significant cytocidal activity was observed for the encapsulation complex of a 2,6-diiodo-8-dimethylaminophenyl-3,5-dithienylvinyleneBODIPY dye with less than 50% viable cells observed at concentrations >= 20 mu g.mL(-1).
Dye sensitized solar cells (DSSCs) were fabricated by using 2(3,5-biscarboxyphenoxy), 9(10), 16(17), 23(24)-tri(tertbutyl) phthalocyaninato Cu (4) and Zn (5) complexes as dyes on the ITO-TiO2 photoanodes containing reduced graphene oxide nanosheets (rGONS) or nitrogen-doped rGONS (NrGONS). The evaluation of the assembled DSSCs revealed that using ITO-TiO2-NrGONS-CuPc photoanode had the highest fill factor (FF) and power conversion efficiency (eta) of 69% and 4.36% respectively. These results show that the asymmetrical phthalocyanine complexes (4) and (5) exhibit significant improvement on the performance of the DSSC compared to our previous work on symmetrical carboxylated phthalocyanines with eta = 3.19%.
Er3+-Yb3+ co-doped Ba-5(PO4)(3)OH nanoparticle powder phosphors were successfully synthesized by urea combustion method. The resulting powder phosphors were characterized using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), high resolution scanning electron microscopy (HRSEM), energy dispersive X-ray spectroscopy (EDS), X-ray photoelectron spectroscopy (XPS) and photoluminescence spectroscopy (PL). XRD data confirmed crystallization of pure hexagonal phase of Ba-5(PO4)(3)OH and HRSEM images showed formation of ellipsoidal particles. XPS data combined with EDS analysis confirmed the materials composition that corresponds with identification of all the chemical elements constituting the materials. The in vitro dark cytotoxicity of the particles confirmed lack of cytocidal behaviour in the absence of light, but considerable photodynamic therapy (PDT) activity was observed upon illumination. Upon excitation using a 980 nm laser, multiple emission peaks in the green and red regions corresponding to the optical transitions of Er3+ ion were observed. Upon co-doping with Yb3+, upconverted red emission was detected and this was attributable to non-radiative energy transfer from Yb3+ to Er3+. The proposed mechanism of upconversion photoluminescence is discussed. (C) 2021 Elsevier B.V. All rights reserved.